Yao, Zhan
Yaeger, Rona
Rodrik-Outmezguine, Vanessa S.
Tao, Anthony
Torres, Neilawattie M.
Chang, Matthew T.
Drosten, Matthias
Zhao, Huiyong
Cecchi, Fabiola
Hembrough, Todd
Michels, Judith
Baumert, Hervé
Miles, Linde
Campbell, Naomi M.
de Stanchina, Elisa
Solit, David B.
Barbacid, Mariano
Taylor, Barry S.
Rosen, Neal
Article History
Received: 5 March 2016
Accepted: 14 June 2017
First Online: 2 August 2017
Competing interests
: N.R. is on the scientific advisory board of and receives research funding from Chugai, and is on the scientific advisory board of and owns stock in Beigene, Wellspring and Kura. N.R. is also on the scientific advisory board of Daiichi-Sankyo, Astra-Zeneca and Takeda, and is a consultant to Novartis. V.S.R.-O. is now an employee of Novartis Pharmaceutical Corporation as Precision Medicine Associate Director. F.C. is an employee at NantOmics, LLC. T.H. is the President of Proteomics at NantOmics and owns the stock.